Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)
Cécile Yelnik(Inserm), Doruk Erkan(Hospital for Special Surgery), Denis Wahl(Inserm), Vittorio Pengo(University of Padua), Maria Efthymiou(University College London), Nina Kello(Northwell Health), Savino Sciascia(Ospedale San Giovanni Bosco), Ann E. Clarke(University of Calgary), Élodie Drumez(Université de Lille), María Laura Bertolaccini(St Thomas' Hospital), Guillermo Pons‐Estel(Hospital Provincial de Rosario), Leslie Skeith(University of Calgary), Bahar Artım-Esen(Istanbul University), Ricard Cervera(Hospital Clínic de Barcelona), Cecilia Nalli(University of Brescia), José Pardos‐Gea(Vall d'Hebron Hospital Universitari), Lanlan Ji(Peking University), Flávio Signorelli(Universidade do Estado do Rio de Janeiro), Yu Zuo(University of Michigan), H. Michael Belmont(New York University), Rohan Willis(The University of Texas Medical Branch at Galveston), C. López-Pedrera(Instituto Maimónides de Investigación Biomédica de Córdoba), D. Ware Branch(University of Utah), Hannah Cohen(University College London Hospitals NHS Foundation Trust), Maria Gerosa(Istituto Ortopedico Gaetano Pini), Maria G. Tektonidou(National and Kapodistrian University of Athens), Paul R. Fortin(Centre hospitalier de l'Université Laval), Zeynep Belce Erton(Hospital for Special Surgery), Danieli Andrade(Universidade de São Paulo), Dachi Cheildze(Yale New Haven Hospital), Hui Shi(Shanghai Jiao Tong University), Megan R W Barber(University of Calgary), Tatsuya Atsumi(Hokkaido University), Robert Roubey(Center for Rheumatology), Esther Rodríguez-Almaraz(Hospital Universitario 12 De Octubre), Michelle Petri(Johns Hopkins University), Guillermo Ruiz‐Irastorza(BioCruces Health research Institute)
Cited by 7
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis
|Arthritis & Rheumatism|2002|574